We demonstrated that the “highly infiltrated” CRCs have a defect in Th1 cytotoxic signature, an excess of inhibitory checkpoint molecule PD-L1 and are likely rich in IL1R1+ Tregs, a subset of cancer-specific and high immunosuppressive Tregs. The gene discussed is IL1R1; the disease is cancer.